secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0000950170-24-061837
Event type: litigation
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma obtains preliminary approval for derivative lawsuit settlement with governance reforms
--------------------------------------------------------------------------------

- Court preliminary approval on May 3, 2024; final hearing set for July 18, 2024.
- Settlement requires Athira to adopt corporate governance reforms and pay lead plaintiffs' attorney's fees, expenses, and service awards.
- Derivative actions Bushansky v. Kawas and Houlihan v. Kawas covered by the Stipulation of Settlement dated March 15, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000095017024061837/0000950170-24-061837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000095017024061837/atha-20240503.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-061837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer